More on TARS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $57.69 |
|
|||
| Open | $57.38 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $59.95 | ||||
| Day Low | $57.38 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 971,198 | ||||
- Tarsus Pharmaceuticals CCO to depart for medical device CEO role
- Form 8-K Tarsus Pharmaceuticals, For: Jul 13
- Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
- H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
- Form 8-K Tarsus Pharmaceuticals, For: Jul 06
- Tarsus acquires iRenix Medical for up to $565M in eye care deal
- Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
- Tarsus shares fall after short seller report
- Culper Research short Tarsus Pharmaceuticals
- Form 4 Tarsus Pharmaceuticals, For: Jun 25 Filed by: Goldberg Andrew D.
Entities mentioned with TARS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
